Abstract
Skin cancer is the most prevalent cancer in the United States, affecting approximately 20% of Americans, with rates increasing annually [1]. By 2040, malignant melanoma is projected to be the second leading cancer [2]. While the majority of skin cancers have low morbidity and mortality, malignant melanoma causes significant morbidity and mortality, accounting for 80% of skin cancer related deaths [3]. Because early-stage melanomas have improved outcomes, early detection and treatment is imperative. However, the 2023 United States Preventative Task Force (USPTF) called for more research in order to determine skin cancer screening recommendations and made a grade B recommendation for counseling 6-month to 24-year-olds regarding minimizing exposure to Ultraviolet (UV) radiation with fair skin to prevent skin cancer [4].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
